Today, the One Health Global Leaders Group on Antimicrobial Resistance was announced by the United Nations Tripartite organizations World Health Organization, UN Food and Agriculture Organization, and the International Organization on Animal Health. ReAct has written an open letter to the Group's co-chairs their Excellencies, Sheikh Hasina, Prime Minister of Bangladesh and Mia Mottley, Prime Minister of Barbados.
The Political Declaration on AMR of the UN General Assembly in 2016 called for an ad hoc Interagency Coordination Group (IACG) to provide practical guidance for approaches needed to ensure sustained effective global action to address antimicrobial resistance. In its recommendations issued in April 2019, the IACG recommended the establishment of three new global governance mechanisms:
- A One Health Global Leaders Group;
- a multi-stakeholder partnership platform, and
- an Independent Panel on Evidence.
Earlier this year, the UN Secretary General approved the Terms of Reference for the One Health Leaders Group and delegated the establishment of it to the Directors-General of the Tripartite organizations.
Today, the One Health Global Leaders Group on Antimicrobial Resistance was launched by the United Nations Tripartite organizations World Health Organization (WHO), UN Food and Agriculture Organization (FAO), and the International Organization on Animal Health (OIE).
ReAct Open Letter to co-chairs of the Global Leaders Group
ReAct has sent an open letter to the co-chairs of the Global Leaders Group. The letter was sent to express ReAct’s views on the need of a renewed global leadership, systems thinking and sustainable financing, and calls on the Global Leaders Group to develop a clear roadmap on its priorities and goals to which it should hold itself accountable.
Five key points from the ReAct Open Letter
- There has been a slow progress to act on the commitments made in the Political Declaration adopted by the UN General Assembly in 2016. There is a need to elevate antimicrobial resistance to the highest level on the global health and development agenda.
- The recommendations from the IACG should be a guiding platform for the work of the Global Leaders Group.
- The success of global governance for AMR will depend on the swift creation and function of the two remaining mechanisms proposed by the IACG: the Independent Panel on Evidence, and the Partnership Platform.
- There is a need for a systems thinking as antimicrobial resistance is jeopardizing the achievement of many of the Sustainable Development Goals.
- We anticipate that the GLG will be important to secure political consensus among governments that can direct policy makers to address the challenge of AMR in a holistic manner across different sectors.
More news and opinion
- ReAct Asia Pacific: Winners of 2020 photography competition
- WAAW ReAct Africa: Engaging civil society and students
- WAAW in Indonesia: Focus on One Health approach to AMR
- Innovate4Health’s 32 finalist teams: For social innovations to address emerging infectious diseases!
- ReAct Open Letter: 5 key points to One Health Global Leaders Group on Antimicrobial Resistance
- New ReAct Report: Treatment of newborn sepsis is threatened – effective antibiotics essential
- Upcoming ReAct Africa Conference: What is the status of the NAPs on AMR in the African region?
- Animal welfare and antibiotic resistance in food animals
- ReAct activities for World Antimicrobial Awareness Week 2020
- Dr. Honar Cherif: My patients can recieve 5-10 courses of antibiotics during their cancer treatment
- New ReAct Report: Antibiotic resistance affects men and women differently
- ReAct Asia Pacific: Photo competition for students – health in focus
- 4 take aways from WHO’s first global report on sepsis
- Launch of global student design sprint – Innovate4Health
- World Sepsis Day – antibiotics essential in treatment of sepsis
- The new Pharmaceutical Strategy for Europe – an opportunity to put public interest first
- 4 key reflections on the recently launched WHO GLASS-report
- Key points from ReAct’s comments to the Independent Panel on Evidence
- ReAct Interview: From zoologist to community engagement on AMR
- ReAct Africa expands
- COVID-19 resolution – a missed opportunity to address global pandemic response more broadly
- What everyone needs to know about clinical research
- New ReAct Policy Brief: Successful cancer treatment relies on effective antibiotics
- Impact of COVID-19 on vaccine-preventable diseases and antibiotic resistance
- ReAct Africa and Africa CDC: COVID-19 webinars
- Antibiotic pollution: India scores a global first with effluent limits
- COVID-19 and AMR – what do we know so far?
- Learning from bedaquiline in South Africa – comprehensive health systems for new antibiotics
- ReAct Interview: How does antibiotics in food animal production end up in the environment?
- Key take aways from CSO workshop on AMR in Kenya
- New fact sheet: Effective antibiotics – essential for childrens’ survival
- Shortages and AMR – why should we care? 4 consequences of antibiotic shortages
- Our microbiome and noncommunicable diseases
- The 2020 AMR Benchmark Report – concerning findings with questionable framing
- 4 key reflections from engaging hospitals in India for antibiotic stewardship
- Teacher Gustavo Cedillo, Ecuador, teaches children about the bacterial world